Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer

British Journal of Radiology

Volumn 81, Issue 969, 2008, Pages 749-752

  Fuwa, Nobukazu ^a   Suzuki, M ^b   Sakurai, Y ^b   Nagata, K ^b   Kinashi, Y ^b   Masunaga, S ^b   Maruhashi, A ^b   Imahori, Y ^c   Kodaira, T ^a   Tachibana, H ^a   Nakamura, T ^a   Ono, K ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Cancer Intelligence Care Systems Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BORONOPHENYLALANINE F 18; BORONOPHENYLALANINE FRUCTOSE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL KILLING; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HEADACHE; HUMAN; MALE; NAUSEA; NEUTRON CAPTURE THERAPY; PAIN; RECURRENT CANCER; TREATMENT RESPONSE; TUMOR CELL;

ADULT; AGED; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 51349100326     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/65306248     Document Type: Article

References (13)

1. Coderre JA, Morris GM. The radiation biology of boron neutron capture therapy. Radiat Res 1999;151:1-18.
2. Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 2004;61:1069-73.
3. Suzuki M, Masunaga S, Kinashi Y, Nagata K, Sakurai Y, Nakamatsu K, et al. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model. Int J Radiat Oncol Biol Phys 2004;59:260-6.
4. Suzuki M, Sakurai Y, Nagata K, Kinashi Y, Masunaga S, Ono K, et al. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys 2006;66:1523-7.
5. ICRP Publication 92: Relative Biological Effectiveness (RBE), Quality Factor (Q) and Radiation Weighting Factor (wR). International Commission on Radiological Protection 2004.
6. Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 1998;39:325-33.
7. Sakurai Y, Kobayashi T. Spectrum evaluation at the filter modified neutron irradiation field for neutron capture therapy in Kyoto University Research Reactor. Nucl Instr Meth A 2004;53:585-95.
8. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979: 14-27.
9. Sakurai Y, Kobayashi T. Controllability of depth dose distribution for neutron capture therapy at the Heavy Water Neutron Irradiation Facility of Kyoto University Research Reactor. Med Phys 2002;29:2338-50.
10. Kullberg EB, Wei Q, Capala J, Giusti V, Malmstrom PU, Gedda L. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation. Int J Radiat Biol 2005;81:621-9.
11. Lesnikowski ZJ, Paradowska E, Olejniczak AB, Studzinska M, Seekamp P, Schussler U, et al. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates. Bioorg Med Chem 2005;13:4168-75.
12. Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 2004;98:195-207.
13. Renner MW, Miura M, Easson MW, Vicente MG. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy. Anticancer Agents Med Chem 2006;6:145-57.